APA (7th ed.) Citation

Alaaeldin, R., Ali, F. E. M., Bekhit, A. A., Zhao, Q., & Fathy, M. (2022). Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan. MDPI AG.

Chicago Style (17th ed.) Citation

Alaaeldin, Rania, Fares E. M. Ali, Amany Abdlrehim Bekhit, Qing-Li Zhao, and Moustafa Fathy. Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan. MDPI AG, 2022.

MLA (9th ed.) Citation

Alaaeldin, Rania, et al. Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan. MDPI AG, 2022.